a Cure for coronavirus should come into the clinic on June 11. “Aviewer” – the first was by the Ministry of health of the Russian drug. He is now at the final stage of clinical trials. Read more about drugs from COVID-19 and their effectiveness on air of TV channel “Russia 1” said the associate Professor of the Department of infectious diseases PFUR, candidate of medical Sciences Sergey Voznesenskiy.
we Already know that “Avidavit” (international name substance – “Favipiravir”, also published under the title “Avigan”) almost halves the duration of illness. In addition, the drug has been well studied, as was in circulation in Japan in 2014 – there it was used against severe forms of influenza. In Japan, however, has deferred the approval of this drug.
according to the expert, with any medication there are two main metrics: efficiency and safety. Indicators such as safety, already tested 180 subjects.
“We know what the side effects from this drug wait, what contraindications exist. The second measure is efficiency. And Japanese researchers, and our developers received the first positive results of the effectiveness of the drug is directly against the new coronavirus infection, noted ascension. But to confirm this, currently running a second wave of studies with a much larger number of participants”.
Among the side effects “of Avifauna” expert called to be teratogenic, that is, the ability to affect the fetus during pregnancy. Accordingly, it is contraindicated for expectant mothers.
“Hard to tolerate this drug people with liver disease, with kidney disease, the drug also adversely affects hematopoiesis, but these side effects and contraindications – they are known to us. If in the lab these indicators to monitor, we can avoid neblogoswelcome impact substances” – added the ascension.
on 1 June it was reported that “Aviewer” will soon begin to arrive at hospitals. About 20 thousand packages have already been made and production volume grows. By the way, the effectiveness of the drug first said China was the world’s first recorded outbreak COVID-19. There he showed the best results among the hundreds of drugs that have tried to treat this disease.
